Allergan Inc. (AGN) Tops Q1 EPS by 3c; Guides Q2, Raises FY11 Outlook
Tweet
Share
E-mailGet Alerts AGN Hot Sheet
Price: $193.02 --0%
Financial Fact:
Operating income: 392.8M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Operating income: 392.8M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Allergan Inc. (NYSE: AGN) reported Q1 EPS of $0.77, $0.03 better than the analyst estimate of $0.74. Revenue for the quarter came in at $1.25 billion versus the consensus estimate of $1.22 billion.
Allergan Inc. sees Q2 EPS of $0.93-$0.95, versus the consensus of $0.92.
Raises its FY11 EPS guidance from $3.54-$3.60 to $3.56-$3.62, vs. the consensus of $3.61.
Allergan Inc. sees Q2 EPS of $0.93-$0.95, versus the consensus of $0.92.
Raises its FY11 EPS guidance from $3.54-$3.60 to $3.56-$3.62, vs. the consensus of $3.61.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
- Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
